source
- Deerfield Management teams with AWS to boost AI-driven life-science venturesDeerfield Management announced a collaboration with Amazon Web Services aimed at accelerating AI-native healthcare and life-science companies in its portfolio. The agreement links AWS's generative…
- AbCellera halts development of OX40 antibody ABCL575 after phase-1 trialAbCellera announced it will not move ABCL575 beyond phase 1, ending its OX40 program. The phase-1 study met its endpoints, showing a favorable tolerability profile and pharmacokinetics that suppor…